Showing results (1-10 of 12) with videos related to
Sort By:
Pageof 2
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|February 5, 2020
Blunted highs: Pharmacodynamic and behavioral models of cannabis toleranceJ G Ramaekers, N L Mason, E L TheunissenBritish Journal of Cancer|March 1, 1981
Effect of renal dysfunction in dogs on the disposition and marrow toxicity of melphalanD S Alberts, H G Chen, D Benz, et al.Psychopharmacology|April 29, 2022
The use patterns of novel psychedelics: experiential fingerprints of substituted phenethylamines, tryptamines and lysergamidesP Mallaroni, N L Mason, F R J Vinckenbosch, et al.Scientific Reports|February 15, 2022
Functional brain connectomes reflect acute and chronic cannabis useJ G Ramaekers, N L Mason, S W Toennes, et al.Journal of Psychoactive Drugs|January 25, 2019
A First-in-Man Study with 4-Fluoroamphetamine Demonstrates it Produces a Mild Psychedelic StateK P C Kuypers, E B De Sousa Fernandes Perna, E L Theunissen, et al.Psychopharmacology|August 15, 2018
Sub-acute and long-term effects of ayahuasca on affect and cognitive thinking style and their association with ego dissolutionM V Uthaug, K van Oorsouw, K P C Kuypers, et al.Gynecologic Oncology|February 1, 1987
Doxorubicin-cisplatin-vinblastine combination chemotherapy of advanced endometrial carcinoma: a Southwest Oncology Group StudyD S Alberts, N L Mason, R V O'Toole, et al.Translational Psychiatry|April 9, 2021
Spontaneous and deliberate creative cognition during and after psilocybin exposureN L Mason, K P C Kuypers, J T Reckweg, et al.Psychopharmacology|March 11, 2021
A placebo-controlled study of the effects of ayahuasca, set and setting on mental health of participants in ayahuasca group retreatsM V Uthaug, N L Mason, S W Toennes, et al.Psychopharmacology|June 2, 2018
Drug liking and wanting, not impulsive action or reflection is increased by 4-fluoroamphetamineK P C Kuypers, E B de Sousa Fernandes Perna, P C Dolder, et al.Pageof 2